Get more info

Get more information
on LUCENTIS:
1-866-LUCENTIS
(1-866-582-3684)
Monday-Friday
8AM-9PM (EST)

 


Click here for tips and tools for managing AMD.

How one woman learned to cope with AMD.
Be Informed
   

Over time, after getting regular treatments of LUCENTIS® (ranibizumab injection), nearly all patients noticed an improvement in their vision—or noticed that their vision stayed the same. Blurry vision and wavy lines may also lessen.

In 2 clinical studies, patients were given LUCENTIS on 2 different treatment schedules. Patients were given LUCENTIS monthly in 1 study. In another study, patients were given 4 monthly LUCENTIS injections and then received injections once every 3 months. Treating with LUCENTIS monthly gives you the best chance to improve your vision. Patients that received LUCENTIS monthly for only 4 months saw a gradual loss in their vision (approximately 5 letters or 1 line) over the following 9 months.

Because everyone is different, your retina specialist will regularly monitor your vision and determine the right treatment schedule for you.

In fact, after 1 year, patients treated monthly with LUCENTIS experienced the following results:

  • 95% of patients had their eyesight stay the same (lost fewer than 15 letters or 3 lines)


  • 70% of patients could see at least 1 more letter on the eye chart


  • Up to 40% of patients had a significant improvement of at least 3 more lines (15 letters) on the eye chart


  • Up to 40% of patients achieved vision of 20/40 or better

There is no cure for wet AMD. But it can become a manageable condition by treating it regularly with LUCENTIS.

Looking ahead...

To get the most out of your treatment, track your progress every day. Use an Amsler grid to test your vision. Make a note of any changes in your vision and be sure to share this information with your retina specialist Click here for an Amsler grid and instructions for use.

If you have wet AMD in only 1 eye, it is important to regularly check your vision in the other because there is a chance you will develop AMD in both eyes. If you notice any changes in your other eye, tell your retina specialist. Early detection is important for timely treatment.

Remember to see your retina specialist regularly and treat your AMD as he or she suggests. If you continue to lose vision, call your retina specialist right away.





Types of AMD




Who is LUCENTIS for?


LUCENTIS® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (AMD).


Important LUCENTIS Safety Information


Like any prescription medication, LUCENTIS is not for everyone. You should not use LUCENTIS if you have an infection in or around the eye.


Like other injections given into the eye, serious eye infection (endophthalmitis) and detached retina have occurred with LUCENTIS. Increases in eye pressure have been seen within 1 hour of an injection. Your eye doctor should monitor your eye pressure and eye health during the week after the injection. If your eye becomes red, sensitive to light, painful, or has a change in vision, you should seek immediate care from your eye doctor.


Although uncommon, conditions associated with eye- and non–eye-related blood clots (arterial thromboembolic events) may occur.


Serious side effects related to the injection procedure were rare. These included serious eye infection, detached retina, and cataract. Other uncommon serious side effects included inflammation inside the eye and increased eye pressure.


The most common eye-related side effects were red eye, eye pain, small specks in vision, the feeling that something is in your eye, and increased tears. The most common non–eye-related side effects were high blood pressure, nose and throat infection, and headache.


LUCENTIS is for prescription use only.

Individual results with LUCENTIS may vary.


Please see LUCENTIS full Prescribing Information.